Skip to content

A patent review of SHP2 allosteric inhibitors (2018-present)

The presence of over 100 patents on SHP2 inhibitors underscores the target’s importance and potential impact in drug discovery and therapeutic applications in oncology.

Our resident experts, Alessia Petrocchi and Alina Ciammaichella have just published a comprehensive review on the topic.

Petrocchi, A., & Ciammaichella, A. (2024). A patent review of SHP2 allosteric inhibitors (2018-present). Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2024.2365410

IRBM IN THE NEWS

PRESS RELEASES

EVENTS

Back To Top